Innova Captab IPO is going to list on stock exchange on Friday, December 29, 2023. It will list on the BSE and NSE stock exchange.
Innova Captab Limited IPO opens for subscription on December 21, 2023 and closes on December 26, 2023. Price range of per share is at ₹426 to ₹448. The total issue is of Rs.570 crores from which Rs. 320 crores will raise from fresh issue of shares and 250 crores from offer for sale.
The lot size for an application is 33 shares per lot which comes to Rs. 14784 for retail investors. The minimum investment for sNII have is 14 lots and for bNII is 68 lots which comes to Rs. 2,06,976 and Rs. 10,06,312 respectively.
innova captab ipo Schedule
| Particulars | Date |
| IPO open for subscription | December 21, 2023 |
| IPO close for subscription | December 26, 2023 |
| Allotment of shares | December 27, 2023 |
| Listing Date | December 29, 2023 |
Innova captab limited financial information
Amount in Crores
| Particulars | For the period ended June 30, 2023 | For the year ended March 31, 2023 | For the year ended March 31, 2022 | For the year ended March 31, 2021 |
| Revenue | 234.37 | 935.58 | 803.41 | 412.03 |
| Net Profit | 17.81 | 67.9 | 63.71 | 34.42 |
| Total Equity | 365.51 | 276.51 | 208.61 | 144.82 |
Amount in Rs.
| Particulars | For the period ended June 30, 2023 | For the year ended March 31, 2023 | For the year ended March 31, 2022 | For the year ended March 31, 2021 |
| EPS | 3.67 | 14.16 | 13.32 | 7.19 |
| Growth in Revenue YOY | – | 16% | 95% | – |
The P/E ratio of the company at the price point of Rs. 448 is 32; for P/E calculation we’re taking the EPS of March 31, 2023. The Total Market capitalisation of Innova Captab Limited at price of Rs. 448 per share is INR 2,563.70 crores.
About Innova captab limited IPO
Innova Captab Limited is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports. Their business includes (i) a contract development and manufacturing organization (“CDMO”) business providing manufacturing services to Indian pharmaceutical companies, (ii) a domestic branded generics business and (iii) an international branded generics business. They have two manufacturing facilities in Baddi, Himachal Pradesh.
Objects of the offer of Innova Captab Limited IPO
The Offer comprises the Fresh Issue by our Company and the Offer for Sale by the Selling Shareholders.
Fresh issue
Innova Captab proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:
1. Repayment and / or prepayment in part or in full, of certain outstanding loans of our Company;
2. Investment in our Subsidiary, UML, for repayment and / or prepayment in part or full of outstanding loans availed by UML;
3. Funding our working capital requirements; and
4. General corporate purposes
The details of the proceeds of the Fresh Issue are summarised in the table below.
| Particulars | Amount | Year in which proceeds used |
| Repayment and / or prepayment, in part or in full, of certain outstanding loans of our Company | 144 | 2024 |
| Investment in our Subsidiary, UML, for repayment and / or prepayment in part or full of outstanding loans availed by UML | 23.6 | 2024 |
| Funding our working capital requirements | 72 | 2024 and 2025 |
| General corporate purposes | – | – |
Offer for sale
Each of the Selling Shareholders will be entitled to their respective portion of the proceeds of the Offer for Sale, after deducting their respective portion of the Offer related expenses and relevant taxes thereon. Company will not receive any proceeds from the Offer for Sale by the Selling Shareholders and the proceeds from the Offer for Sale will not form part of the Net Proceeds. For detailed information regarding offer you can see Innova Captab Limited RHP.
DOMS IPO Detail